Carcinoid crisis 24 hours after bland embolization: A case report

BioScience Trends

Volumn 4, Issue 3, 2010, Pages 143-144

  Fujie, Sayuri ^a   Zhou, Wendy ^a   Fann, Patricia ^a   Yen, Yun ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

Carcinoid crisis; Carcinoid syndrome; Octreotide; Prevention

Indexed keywords

ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; OCTREOTIDE;

AGED; ARTICLE; ARTIFICIAL EMBOLISM; CARCINOID SYNDROME; CASE REPORT; HUMAN; LIVER TUMOR; MALE; METASTASIS; PATHOLOGY; PATHOPHYSIOLOGY; TREATMENT OUTCOME;

AGED; ANTINEOPLASTIC AGENTS, HORMONAL; EMBOLIZATION, THERAPEUTIC; HUMANS; LIVER NEOPLASMS; MALE; MALIGNANT CARCINOID SYNDROME; NEOPLASM METASTASIS; OCTREOTIDE; TREATMENT OUTCOME;

EID: 77957063787     PISSN: 18817815     EISSN: 18817823     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Modlin IM, Sandor A. An analysis of 8305 cases of carcinoid tumors. Cancer. 1997; 79:813-829.
2. Oberg KE. Carcinoid and flushing syndromes. In: Surgical Endocrinology, Chapter 28. Lippincott Williams and Wilkins, Philadelphia, PA, USA, 2001; pp. 405-412.
3. Kulke MH, Mayer RJ. Carcinoid tumors. N Engl J Med. 1999; 340:858-868.
4. Akerström G, Falconi M, Kianmanesh R, Ruszniewski P, Plöckinger U.; Mallorca Consensus Conference participants; European Neuroendocrine Tumor Society. ENETS consensus guidelines for the standards of care in neuroendocrine tumors: Pre- and perioperative therapy in patients with neuroendocrine tumors. Neuroendocrinology. 2009; 90:203-208.
5. Ramage JK, Davies AH, Ardill J, et al., UKNETwork for Neuroendocrine Tumours. Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours. Gut. 2005; 54 Suppl 4: iv1-16.
6. Graham GW, Unger BP, Coursin DB. Perioperative management of selected endocrine disorders. Int Anesthesiol Clin. 2000; 38:31-67
7. Bissonnette RT, Gibney RG, Berry BR, Buckley AR. Fatal carcinoid crisis after percutaneous fine needle biopsy of hepatic metastasis. Radiology. 1990; 174:751-752.
8. Majeed F, Porter TR, Tarantolo S, Duhachek-Stapelman A, Xie F, Elhendy A. Carcinoid crisis and reversible right ventricular dysfunction after embolization in untreated carcinoid syndrome. Eur J Echocardiogr. 2007; 8:386-389.
9. McPherson A, Regan J, Jackson N. The case report and palliative management of a patient with carcinoid syndrome and crises. J Palliat Med. 2009; 12:743-745.
10. Kinney MA, Warner ME, Nagorney DM, Rubin J, Schroeder DR, Maxson PM, Warner MA. Perianaesthetic risks and outcomes of abdominal surgery for metastatic carcinoid tumors. Br J Anaesth. 2001; 87:447-452.
11. Koopmans KP, Brouwers AH, De Hooge MN, Van der Horst-Schrivers AN, Kema IP, Wolffenbuttel BH, De Vries EG, Jager PL. Carcinoid crisis after injection of 6-18F-fluorodihydroxyphenylalanine in a patient with metastatic carcinoid. J Nucl Med. 2005; 46:1240-1243.
12. Hughes EW, Hodkinson BP. Carcinoid syndrome: the combined use of ketanserin and octreotide in the management of an acute crisis during anaesthesia. Anaesth Intensive Care. 1989; 17:367-370.